Incyte is attempting to enter the competitive market for atopic dermatitis with ...
After an initial deal of $81 million in June 2022, Novartis and Samsung have dec...
After experiencing trouble with observations in February, Outset Medical has rec...
Sino-American biotech company BeiGene has announced its acquisition of China-bas...
The Food and Drug Administration (FDA) in the U.S. has completely lifted the par...
Travelers and medical professionals from the U.S. who are hoping for a different...
According to the results of a late-stage clinical trial, Opdivo, an immunotherap...
Tessa Therapeutics, a biotech company based in Singapore, has halted its operati...
The European Medicines Agency (EMA) has launched a thorough review of Novo Nordi...
Renalytix has achieved a significant milestone after a challenging three-year jo...
J&J shared results from its phase 2 trial for JNJ-2113, an oral psoriasis drug f...
Amneal Pharmaceuticals were positive about launching their extended-release trea...
AstraZeneca announced the main findings of a Phase III trial for an antibody-dru...
Celltrion Healthcare, a biopharmaceutical company based in South Korea, has anno...
Gelesis, a company specializing in oral hydrogel technology, received FDA cleara...
Alopecia areata, the most prevalent form of alopecia affecting individuals of al...
